Evan Chen is a Palo Alto, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Evan Chen is A180147 for Ophthalmology in California. Evan Chen is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Evan Chen speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
2452 Watson Ct, Palo Alto, California, 94303-3216
Phone:
650-723-6995
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1821675091
NPI Enumeration Date:
25 Mar, 2021
NPI Last Update On:
11 Feb, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Evan Chen are as mentioned below.
License Number
Specialization
State
Status
A180147
Ophthalmology
California
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2452 Watson Ct, Palo Alto, California
Zip:
94303-3216
Phone Number:
--
Fax Number:
--
Patients can reach Evan Chen at 2452 Watson Ct, Palo Alto, California or can call to book an appointment on 650-723-6995. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.